Every material Form 8-K Planet Labs PBC has filed with the SEC since June 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Planet Labs reported record second-quarter fiscal 2027 revenue of $116.1 million, up 58% from a year earlier, and a net loss of $9.4 million, narrower than the $22.6 million loss a year earlier. Adjusted EBITDA profit rose to $13.9 million from $6.4 million, and cash, cash equivalents and short-term investments reached $865.4 million. The company also gave outlook for the third quarter and full fiscal 2027, but the filing does not compare this outlook with any earlier guidance.
Q2 revenue $116.1 million, up 58% year over year; gross margin 57% versus 58% a year earlier
Q2 net loss $9.4 million versus $22.6 million a year earlier; GAAP net loss per share $0.03
Q3 fiscal 2027 revenue expected at $101 million to $105 million, with an adjusted EBITDA loss of $1 million to $6 million
Full fiscal 2027 revenue expected at $430 million to $441 million, with adjusted EBITDA profit of $3 million to $10 million
Planet Labs PBC entered into an Equity Distribution Agreement on June 5, 2026, allowing it to sell up to $1.5 billion of Class A common stock through an at-the-market program, including forward sale arrangements with banks. The filing says the shares will be sold under a shelf registration on Form S-3, and sales will be made at the Company's direction and price parameters. Because new shares could dilute existing holders, the program matters to shareholders, though the filing does not state how much stock has been sold so far.
Company may also enter into forward sale agreements with Goldman Sachs Bank USA and Citibank, N.A., with settlement in shares or cash
Sales agents commission of up to 2% of gross sales price per share sold through them as agent
Planet Labs reported fiscal first-quarter 2027 revenue of $94.2 million, up 42% year over year and described as a record, with backlog up 72% to over $906 million. The company posted a net loss of $138.9 million, compared with $12.6 million a year earlier, including a roughly $106.5 million warrant revaluation loss, and its adjusted EBITDA swung to a loss of $1.0 million from a $1.2 million profit.
Q1 revenue of $94.2 million, up 42% year over year; quarter ended April 30, 2026
Q1 net loss of $138.9 million vs. $12.6 million a year earlier, including an approximate $106.5 million warrant revaluation loss
Q2 revenue guidance of approximately $102 million to $107 million; full fiscal 2027 revenue guidance of approximately $425 million to $441 million
Cash, cash equivalents and short-term investments of $730.8 million at quarter end
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Planet Labs PBC filing is on SEC EDGAR ↗. 8-K briefs of other companies →